Page last updated: 2024-09-02
7-o-(2,6-dideoxy-2-fluoro-alpha-talopyranosyl)adriamycinone- 14-beta-alaniate hydrochloride and Liver Neoplasms
7-o-(2,6-dideoxy-2-fluoro-alpha-talopyranosyl)adriamycinone- 14-beta-alaniate hydrochloride has been researched along with Liver Neoplasms in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Kang, KW; Kim, SG; Kim, SH; Kim, WB; Son, MH; Sung, M | 1 |
Other Studies
1 other study(ies) available for 7-o-(2,6-dideoxy-2-fluoro-alpha-talopyranosyl)adriamycinone- 14-beta-alaniate hydrochloride and Liver Neoplasms
| Article | Year |
|---|---|
DA-125, a novel anthracycline derivative showing high-affinity DNA binding and topoisomerase II inhibitory activities, exerts cytotoxicity via c-Jun N-terminal kinase pathway.
Topics: Animals; Antineoplastic Agents; beta-Alanine; Carcinoma, Hepatocellular; DNA, Neoplasm; Doxorubicin; Enzyme Inhibitors; JNK Mitogen-Activated Protein Kinases; Liver Neoplasms; Mitogen-Activated Protein Kinases; Peroxidase; Rats; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 2001 |